Cyclophosphamide and lymphocyte subpopulations in Wegener's granulomatosis.
D000328:Adult; D000368:Aged; D000818:Animals; D000941:Antigens; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D005260:Female; D014890:Granulomatosis with Polyangiitis / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007104:Immune Adherence Reaction; D066298:In Vitro Techniques; D007958:Leukocyte Count; D008214:Lymphocytes / Q000187:drug effects* / Q000276:immunology; D008297:Male; D008858:Microscopy, Phase-Contrast; D008875:Middle Aged; D008934:Mitogens; D012756:Sheep / Q000276:immunology; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology
D000941:Antigens; D008934:Mitogens; D003520:Cyclophosphamide